Eintrag weiter verarbeiten
Online-Ressource

Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: Journal of Clinical Oncology
Personen und Körperschaften: Trask, P. C., Cella, D., Besson, N., Kelly, V., Masszi, T., Kim, D.
In: Journal of Clinical Oncology, 29, 2011, 15_suppl, S. 6620-6620
Format: E-Article
Sprache: Englisch
veröffentlicht:
American Society of Clinical Oncology (ASCO)
Schlagwörter:
Cancer Research
Oncology
author_facet Trask, P. C.
Cella, D.
Besson, N.
Kelly, V.
Masszi, T.
Kim, D.
Trask, P. C.
Cella, D.
Besson, N.
Kelly, V.
Masszi, T.
Kim, D.
author Trask, P. C.
Cella, D.
Besson, N.
Kelly, V.
Masszi, T.
Kim, D.
spellingShingle Trask, P. C.
Cella, D.
Besson, N.
Kelly, V.
Masszi, T.
Kim, D.
Journal of Clinical Oncology
Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).
Cancer Research
Oncology
author_sort trask, p. c.
spelling Trask, P. C. Cella, D. Besson, N. Kelly, V. Masszi, T. Kim, D. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2011.29.15_suppl.6620 Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML). Journal of Clinical Oncology
doi_str_mv 10.1200/jco.2011.29.15_suppl.6620
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxMS4yOS4xNV9zdXBwbC42NjIw
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxMS4yOS4xNV9zdXBwbC42NjIw
institution DE-Bn3
DE-Brt1
DE-D161
DE-Zwi2
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
imprint American Society of Clinical Oncology (ASCO), 2011
imprint_str_mv American Society of Clinical Oncology (ASCO), 2011
issn 0732-183X
1527-7755
issn_str_mv 0732-183X
1527-7755
language English
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
match_str trask2011healthrelatedqualityoflifehrqolofbosutinibski606inimatinibresistantimrorimatinibintolerantimichronicphasechronicmyeloidleukemiacpcml
publishDateSort 2011
publisher American Society of Clinical Oncology (ASCO)
recordtype ai
record_format ai
series Journal of Clinical Oncology
source_id 49
title Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).
title_unstemmed Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).
title_full Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).
title_fullStr Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).
title_full_unstemmed Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).
title_short Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).
title_sort health-related quality of life (hrqol) of bosutinib (ski-606) in imatinib-resistant (im-r) or imatinib-intolerant (im-i) chronic phase chronic myeloid leukemia (cp cml).
topic Cancer Research
Oncology
url http://dx.doi.org/10.1200/jco.2011.29.15_suppl.6620
publishDate 2011
physical 6620-6620
description
container_issue 15_suppl
container_start_page 6620
container_title Journal of Clinical Oncology
container_volume 29
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792320715823775748
geogr_code not assigned
last_indexed 2024-03-01T10:50:33.121Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Health-related+quality+of+life+%28HRQoL%29+of+bosutinib+%28SKI-606%29+in+imatinib-resistant+%28IM-R%29+or+imatinib-intolerant+%28IM-I%29+chronic+phase+chronic+myeloid+leukemia+%28CP+CML%29.&rft.date=2011-05-20&genre=article&issn=1527-7755&volume=29&issue=15_suppl&spage=6620&epage=6620&pages=6620-6620&jtitle=Journal+of+Clinical+Oncology&atitle=Health-related+quality+of+life+%28HRQoL%29+of+bosutinib+%28SKI-606%29+in+imatinib-resistant+%28IM-R%29+or+imatinib-intolerant+%28IM-I%29+chronic+phase+chronic+myeloid+leukemia+%28CP+CML%29.&aulast=Kim&aufirst=D.&rft_id=info%3Adoi%2F10.1200%2Fjco.2011.29.15_suppl.6620&rft.language%5B0%5D=eng
SOLR
_version_ 1792320715823775748
author Trask, P. C., Cella, D., Besson, N., Kelly, V., Masszi, T., Kim, D.
author_facet Trask, P. C., Cella, D., Besson, N., Kelly, V., Masszi, T., Kim, D., Trask, P. C., Cella, D., Besson, N., Kelly, V., Masszi, T., Kim, D.
author_sort trask, p. c.
container_issue 15_suppl
container_start_page 6620
container_title Journal of Clinical Oncology
container_volume 29
description
doi_str_mv 10.1200/jco.2011.29.15_suppl.6620
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxMS4yOS4xNV9zdXBwbC42NjIw
imprint American Society of Clinical Oncology (ASCO), 2011
imprint_str_mv American Society of Clinical Oncology (ASCO), 2011
institution DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275
issn 0732-183X, 1527-7755
issn_str_mv 0732-183X, 1527-7755
language English
last_indexed 2024-03-01T10:50:33.121Z
match_str trask2011healthrelatedqualityoflifehrqolofbosutinibski606inimatinibresistantimrorimatinibintolerantimichronicphasechronicmyeloidleukemiacpcml
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
physical 6620-6620
publishDate 2011
publishDateSort 2011
publisher American Society of Clinical Oncology (ASCO)
record_format ai
recordtype ai
series Journal of Clinical Oncology
source_id 49
spelling Trask, P. C. Cella, D. Besson, N. Kelly, V. Masszi, T. Kim, D. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2011.29.15_suppl.6620 Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML). Journal of Clinical Oncology
spellingShingle Trask, P. C., Cella, D., Besson, N., Kelly, V., Masszi, T., Kim, D., Journal of Clinical Oncology, Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML)., Cancer Research, Oncology
title Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).
title_full Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).
title_fullStr Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).
title_full_unstemmed Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).
title_short Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).
title_sort health-related quality of life (hrqol) of bosutinib (ski-606) in imatinib-resistant (im-r) or imatinib-intolerant (im-i) chronic phase chronic myeloid leukemia (cp cml).
title_unstemmed Health-related quality of life (HRQoL) of bosutinib (SKI-606) in imatinib-resistant (IM-R) or imatinib-intolerant (IM-I) chronic phase chronic myeloid leukemia (CP CML).
topic Cancer Research, Oncology
url http://dx.doi.org/10.1200/jco.2011.29.15_suppl.6620